These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 32490826)

  • 21. Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.
    Li SQ; Su LL; Xu TF; Ren LY; Chen DB; Qin WY; Yan XZ; Fan JX; Chen HS; Liao WJ
    World J Gastroenterol; 2023 Jul; 29(26):4186-4199. PubMed ID: 37475840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
    Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
    Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
    Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.
    Yan X; Li Y; Qin W; Liao J; Fan J; Xie Y; Wang Z; Li S; Liao W
    BMC Cancer; 2024 Jun; 24(1):700. PubMed ID: 38849749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
    Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
    Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
    Zhang K; Zhang L; Li WC; Xie SS; Cui YZ; Lin LY; Shen ZW; Zhang HM; Xia S; Ye ZX; He K; Shen W
    Eur Radiol; 2023 Dec; 33(12):8936-8947. PubMed ID: 37368104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
    Zheng BH; Liu LZ; Zhang ZZ; Shi JY; Dong LQ; Tian LY; Ding ZB; Ji Y; Rao SX; Zhou J; Fan J; Wang XY; Gao Q
    BMC Cancer; 2018 Nov; 18(1):1148. PubMed ID: 30463529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
    Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
    Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computed tomography-based radiomics nomogram for the preoperative prediction of perineural invasion in colorectal cancer: a multicentre study.
    Chen Q; Cui Y; Xue T; Peng H; Li M; Zhu X; Duan S; Gu H; Feng F
    Abdom Radiol (NY); 2022 Sep; 47(9):3251-3263. PubMed ID: 35960308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
    Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
    Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT-Based Radiomics Nomogram Improves Risk Stratification and Prediction of Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
    Wu C; Yu S; Zhang Y; Zhu L; Chen S; Liu Y
    Front Oncol; 2022; 12():896002. PubMed ID: 35875140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a radiomics-based nomogram for the preoperative prediction of microsatellite instability in colorectal cancer.
    Ying M; Pan J; Lu G; Zhou S; Fu J; Wang Q; Wang L; Hu B; Wei Y; Shen J
    BMC Cancer; 2022 May; 22(1):524. PubMed ID: 35534797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomics analysis of [
    Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm.
    Chong HH; Yang L; Sheng RF; Yu YL; Wu DJ; Rao SX; Yang C; Zeng MS
    Eur Radiol; 2021 Jul; 31(7):4824-4838. PubMed ID: 33447861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection.
    Li N; Wan X; Zhang H; Zhang Z; Guo Y; Hong D
    BMC Cancer; 2022 Jun; 22(1):664. PubMed ID: 35715783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
    Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
    J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma.
    Wang L; Zhang Y; Li J; Guo S; Ren J; Li Z; Zhuang X; Xue J; Lei J
    Dig Dis Sci; 2023 Dec; 68(12):4521-4535. PubMed ID: 37794295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.